These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8329466)

  • 1. Characterization of multiple acylation sites on a recombinant protein by electrospray mass spectrometry.
    Bouchon B; Van Dorsselaer A; Roitsch C
    Biol Mass Spectrom; 1993 Jun; 22(6):358-60. PubMed ID: 8329466
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry.
    Bouchon B; Klein M; Bischoff R; Van Dorsselaer A; Roitsch C
    Anal Biochem; 1997 Mar; 246(1):52-61. PubMed ID: 9056182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.
    Legros V; Jolivet-Reynaud C; Battail-Poirot N; Saint-Pierre C; Forest E
    Protein Sci; 2000 May; 9(5):1002-10. PubMed ID: 10850810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein A (OspA) complexed with a murine monoclonal antibody Fab fragment.
    Li H; Lawson CL
    J Struct Biol; 1995; 115(3):335-7. PubMed ID: 8573475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
    Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
    J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyme arthritis: lessons learned and to be learned.
    Sigal LH
    Arthritis Rheum; 1999 Sep; 42(9):1809-12. PubMed ID: 10513793
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches toward the directed design of a vaccine against Borrelia burgdorferi.
    Luft BJ; Dunn JJ; Lawson CL
    J Infect Dis; 2002 Feb; 185 Suppl 1():S46-51. PubMed ID: 11865439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistep denaturation of Borrelia burgdorferi OspA, a protein containing a single-layer beta-sheet.
    Koide S; Bu Z; Risal D; Pham TN; Nakagawa T; Tamura A; Engelman DM
    Biochemistry; 1999 Apr; 38(15):4757-67. PubMed ID: 10200164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lyme borreliosis--vaccines in the "pipeline"].
    Kramer M
    MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of lipidation of recombinant Lyme vaccine protein (rOspA) by electrospray mass spectroscopy.
    Wu XD; Marakov KL; Martinez PA; McVerry PH; Malinzak DA
    J Pharm Biomed Anal; 1997 Dec; 16(4):613-7. PubMed ID: 9502157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyme disease: uphill struggle.
    Abbott A
    Nature; 2006 Feb; 439(7076):524-5. PubMed ID: 16452949
    [No Abstract]   [Full Text] [Related]  

  • 13. ACIP issues recommendations for Lyme disease vaccine. Advisory Committee on Immunization Practices.
    Morey SS
    Am Fam Physician; 1999 Nov; 60(7):2171-2. PubMed ID: 10569515
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on OspA: a source of new paradigms in Lyme disease research.
    Philipp MT
    Trends Microbiol; 1998 Feb; 6(2):44-7. PubMed ID: 9507636
    [No Abstract]   [Full Text] [Related]  

  • 16. New vaccine targets Lyme disease. New hope for diminishing the 'great masquerader'.
    Lewis C
    FDA Consum; 1999; 33(3):12-7. PubMed ID: 10443184
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of the single-layer beta-sheet of Borrelia burgdorferi OspA in the absence of the C-terminal capping globular domain.
    Huang X; Nakagawa T; Tamura A; Link K; Koide A; Koide S
    J Mol Biol; 2001 Apr; 308(2):367-75. PubMed ID: 11327773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping Lyme disease at bay. An integrated approach to prevention.
    Wade CF
    Am J Nurs; 2000 Jul; 100(7):26-31; quiz 32. PubMed ID: 10914066
    [No Abstract]   [Full Text] [Related]  

  • 19. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of Lyme disease vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):35-6, 43. PubMed ID: 9933128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.